WO2012074347A2 - 안경 부착형 약물담체 기구장치 - Google Patents
안경 부착형 약물담체 기구장치 Download PDFInfo
- Publication number
- WO2012074347A2 WO2012074347A2 PCT/KR2011/009365 KR2011009365W WO2012074347A2 WO 2012074347 A2 WO2012074347 A2 WO 2012074347A2 KR 2011009365 W KR2011009365 W KR 2011009365W WO 2012074347 A2 WO2012074347 A2 WO 2012074347A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drug carrier
- drug
- frame
- glasses
- attached
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0026—Ophthalmic product dispenser attachments to facilitate positioning near the eye
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/10—Wearable devices, e.g. garments, glasses or masks
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C11/00—Non-optical adjuncts; Attachment thereof
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C2200/00—Generic mechanical aspects applicable to one or more of the groups G02C1/00 - G02C5/00 and G02C9/00 - G02C13/00 and their subgroups
- G02C2200/02—Magnetic means
Definitions
- the present invention relates to an eyeglass-attached drug carrier device, and more particularly, attached to the glasses to administer the drug to the skin or mucous membrane of the face, and in particular, the form of the drug carrier and the fixing means according to the shape of the glasses It relates to a spectacle-type drug carrier device.
- the human eye consists of the eye and the optic nerve, and various symptoms are manifested according to the diseases and disorders of the eye.
- the treatment methods are oral administration of drugs directly, or direct administration through the skin or mucous membranes.
- the oral administration method has a problem that the therapeutic effect is halved as the main active ingredient of the drug passes through the liver, and methods of directly administering the drug to the eye are being considered.
- various eye diseases such as iris, corneal ulcer, scleritis, eye strain, choroidal plexus, glaucoma, trigeminal neuralgia, subconjunctival hemorrhage, conjunctivitis, uveitis, keratinitis, pectene, scleritis and keratitis Research on the administration of drug components that can be expected to prevent and alleviate various eye diseases such as folliculitis, keratoconjunctivitis and quinque edema.
- the conventional drug administration methods have a problem in that the oral administration of the drug component is halved while passing through the liver, and in the case of the direct application to the skin, it is difficult to apply during daily life. There was this.
- the present invention has been made to solve the above problems, and provides a spectacle-attached drug carrier device that can be detachably attached to glasses to supply drugs for eye fatigue recovery and eye disease improvement in life. have.
- the fixing means may be a fixing ring extending from the drug carrier and bent to the frame of the glasses, or the frame of the glasses is a metal material capable of magnetic coupling with a magnet, the fixing means is a magnetic force to the glasses frame It may include a permanent magnet to be combined.
- the eyeglass frame may include a plurality of inlet grooves formed on a surface to which the drug carrier is attached, and the fixing means may include a fixing protrusion protruding from the drug carrier and inserted into the inlet groove.
- the drug carrier is formed to be inclined downward as it extends from the center to both ends so as to be seated on the wearer's nose, the lower surface is formed with the drug carrier, the fixing means extends upward from the drug carrier and wraps the lens
- the connecting ring is connected to the connecting frame for connecting the lens frame, the nose support seating portion for seating the nose support of the glasses may be provided on the upper surface of the drug carrier.
- the drug carrier may include a base frame mounted to the eyeglass frame by the fixing means, and a drug sheet that is detachably installed on the base frame and the medicines are mixed.
- Glasses-attached drug carrier device can be expected to be effective to recover eye fatigue, prevent eye diseases and alleviate the eye fatigue by attaching to the glasses to allow the drug to penetrate through the skin or mucous membrane around the eye during daily life, Attached to the glasses has the advantage of maximizing ease of use.
- FIG. 1 is a perspective view showing a first embodiment of the spectacles-attached drug carrier device according to the invention
- FIG. 1 is an exploded perspective view of FIG. 1;
- FIG. 3 is a cross-sectional view of FIG.
- Figure 4 is a partially cut perspective view showing another embodiment in which the magnet is attached to the base frame
- FIG. 5 is an exploded perspective view showing an embodiment in which the auxiliary lens frame having a polarizing lens in front of the glasses is further mounted,
- Figure 6 is an exploded perspective view showing a second embodiment of the eyeglasses attached drug carrier device
- Figure 7 is an exploded perspective view showing a third embodiment of the eyeglasses attached drug carrier device
- FIG. 8 is an exploded perspective view showing a fourth embodiment of the eyeglass-attached drug carrier device
- FIG. 9 is an exploded perspective view showing the eyeglasses attached drug carrier mechanism device including a fixing means using an adhesive sheet,
- FIG. 10 is an exploded perspective view showing a fifth embodiment of the eyeglass-attached drug carrier device
- FIG. 11 is an exploded perspective view showing a sixth embodiment of the eyeglass-attached drug carrier device
- FIG. 12 is a cross-sectional view of FIG. 11,
- FIG. 13 is a perspective view showing a seventh embodiment of an eyeglass-attached drug carrier device
- FIG. 14 is an exploded perspective view showing a functional glasses equipped with a plurality of drug carriers
- FIG. 15 is a partial partial detached perspective view showing another embodiment in which an attachment portion to which a drug sheet is attached to a lens frame is formed;
- FIG. 16 is an exploded perspective view showing an eighth embodiment of the eyeglass-attached drug carrier device.
- the spectacle-attached drug carrier device 100 of the present embodiment includes a drug carrier 110 and a drug carrier 110. ) Is fixed to the frame 11 of the glasses 10.
- the glasses 10 include a frame 11 that can be worn on a user's face, and a lens 16 installed on the frame 11 to protect or correct a user's vision.
- the frame 11 includes two lens frames 12 surrounding the lens 16, a connecting frame 13 interconnecting the lens frames 12, and a rear end extending from the lens frame 12 so that an end portion of the frame 11 may be disposed. It includes a leg frame 14 to be caught by the ear, the side of the connecting frame 13 or the lens frame 12 is formed so that the nose support 15 is seated on the user's nose and the like.
- the drug carrier 110 is mounted to the frame 11 through a fixing means, to supply drugs for eye fatigue recovery or ocular disease improvement.
- the drug carrier 110 includes a base frame 111 and a drug sheet 113 mounted on the base frame 111.
- the base frame 111 is formed in a thin annular shape and a through-hole 112 penetrating the front and rear surfaces is formed in the center so that the user can wear the eyeglasses attached drug carrier device 100 of the present invention.
- the front is seen through the lens 16.
- the base frame 111 may be formed of a light metal material such as aluminum, or may be formed of synthetic resin or nonwoven fabric.
- the base frame 111 is formed in a rectangular frame shape, but the base frame 111 may be formed in various shapes, such as an oval or a triangle, depending on the shape of the glasses, and an upper side of the lens frame 12. Or it may be formed to be installed only on one side selected from the lower side.
- the drug sheet 113 contains various medicines containing antioxidants for eye recovery or eye disease improvement.
- Lutein Zeaxanthin, Melatonin, Beta-carotene, L-carnitine, Astaxanthin (Astaxanthin), Alpha-lipoic acid, Carnosine, Epigallocatechin gallate, Acetyl-L-carnitine, Curcumin, Anthocyanin ), Drevogenin D, sulforaphane, carotenoids, folic acid, vitamin A, vitamin B, vitamin C, tetramethyl There are such things as pyrazine (tetramethylpyrazine), phystine (fisetin), cannabinoids and vitamin E (Vitamin E).
- the above-mentioned medicinal ingredients are preferably formed by grinding or extracting and stirring natural herbal medicines.
- rutin components include Bupyeong, Gyuja, Grapes, and Yellow Beans. Root, Root Bark, Stirrup, Grape Root, Wager, Wager, Pea, Ginkgo, Sesame Seed ), Silicula, silicula root, mythic root, objectives, encyclopaedia, vulgaris, ginseng ), And red-leaf roots, and the constituents of zeasanchin are cheonsangpi ( ⁇ ), lettuce, ( ⁇ ⁇ ), upper leaf ( ⁇ ⁇ ), ear canal ( ⁇ ), Dokyeongbaekpi ( ⁇ ⁇ ⁇ ) , Taoism, Do-Geun, Do-Geun, Do-Yeop, Do-ji, Do-Kin-Yin, Do-Hwa, Hwa-Jeok-Pear, White Encyclopedia , Regular society, Yacheonma, indong, gold and silver coins It can be extracted from medicinal herb, medicinal herb, dried fruit, dried fruit, dono, doh
- the melatonin component can be extracted from the herbal medicines of Bongdu, Yau, Nadu, and Lobe, and the beta-carotene components are almond and non-horse meat.
- Curcumin ingredient is turmeric ), Turmeric ), Folic acid is sealed and ⁇ , Cheongui, Cheongmil, Ginseng-ro ), From vitamins of ginseng, the components of vitamins are: ogapi, malt, sorghum, lumps of wood, stomach lobe, spring leaf ⁇ , ⁇ ⁇ ⁇ , Shinguk, Rain Leaf, Root Nets, dry aging, aging It can be extracted from flower and non-horse meat, and the vitamin seed ingredient is red skin gun, modifier, chae, and crude flower.
- chrysanthemum, lemon, orange, cherry, pomegranate, grape, strawberry Roses, Lilacs, Acacia, Freesia, Lilies, Lavender, Mint, Jasmine, Wormwood, Rosemary, Brush, Flavono, Fir, Coffee, Inflorescence, Chamemile, Cyprus, Geranium, Juniper, Rosemary, Sage, Lime, Neroli, Sandalwood
- Herbal ingredients such as bergamot, eucalyptus, limeneroli, peppermint, ylang-ylang, patchouli, myrrh, franken sense, cedarwood and sandalwood may be obtained.
- the drug sheet 113 When the drug sheet 113 is liquefied and gelled, and the drug sheet 113 is manufactured in the form of a capsule or a pad, the drug sheet 113 is coupled to the base frame 111 and positioned around the eye. Since the herbal ingredient discharged from the sheet 113 penetrates into the body through the skin of the eye, the herbal ingredient can be used for fatigue recovery or eye disease improvement effect.
- the base frame 111 is repeatedly used, and only the drug sheet 113 is interchanged to minimize replacement costs, depending on the purpose of use of the user.
- various herbal ingredients can be selectively applied according to personal preference.
- the fixing means is for fixing the drug carrier 110 to the lens frame 12 of the glasses 10 as described above.
- the fixing means of the present embodiment has an upper fixing ring 121 protruding from the front upper end of the base frame 111, and a lower fixing ring 122 protruding from the lower front of the base frame 111.
- the upper fixing ring 121 has an end bent downward, and the lower fixing ring 122 only has to support a lower portion of the lens frame 12 so that a predetermined length protrudes forward, and the lower fixing ring 122
- the end portion of the figure may be formed to be bent upward.
- the eyeglass-attached drug carrier device 100 is provided such that the upper fixing ring 121 is caught on the lens frame 12 of the eyeglass 10 so that the base frame 111 having the drug sheet 113 is attached thereto. Attached to (10), and then wearing the glasses 10, the herbal ingredients contained in the drug carrier 110 can penetrate into the body through the skin of the eyes to see the pharmacological effect.
- the fixing means that is a fixing means is fixed to the lens frame 12 is shown in the fixed structure, but the fixing ring is caught on the bridge frame 14 or the connecting frame 13 in addition to the lens frame 12 drug carrier ( 110 may be formed to fix the glasses 10, and in the case of the rimless glasses 10 in which the connecting frame 13 and the leg frame 14 are directly coupled to the lens 16, the fixing ring is the lens 16. It may be formed to hang over the top and bottom of the.
- the drug carrier 110 may be formed so that the adhesive material is applied to the base frame 111 or directly attached to the glasses 1 by the adhesive sheet 128 including the adhesive material as shown in FIG. 9. .
- a magnet is mounted on the attachment surface to which the drug sheet 113 is attached to the base frame 111 so that the molecular motion of the drug substance included in the drug sheet may be activated by the magnet.
- the influence of electromagnetic waves on electronic products that emit electromagnetic waves, such as 3D TVs and monitors, can be minimized.
- the lens 16 may be a vision correction lens or a protective lens, and a polarizing lens for viewing 3D TV may be applied. As shown in FIG. 5, the lens 16 may further include an auxiliary lens frame 20 in which a general lens is applied and a polarizing lens 21 is mounted in front of the lens frame 12.
- FIG. 6 shows an embodiment in which a permanent magnet is applied as a fixing means.
- the base frame 111 of the present embodiment is provided with a permanent magnet piece 124 on the front surface in contact with the lens frame 12.
- the glasses 10 of the present embodiment are formed of a metal whose frame 11 is a magnetic material, and the base frame 111 is detached from the glasses 10 by the permanent magnet piece 124 installed on the base frame 111. It is a structure that is magnetically coupled as possible.
- the fixing means of this embodiment may be formed by coupling the permanent magnet piece 124 to the base frame 111 made of metal or synthetic resin, or the base frame 111 itself may be formed of a permanent magnet having magnetic properties.
- the fixing means may be formed as a fixing protrusion 126 protruding from the base frame 111.
- the lens frame 12 has a fixing groove 127 is formed on the inner surface facing the face, and a fixing protrusion 126 that can be inserted into the fixing groove 127 on the front surface of the base frame 111 is formed The fixing protrusion 126 may be inserted into the fixing groove 127 to fix the drug carrier 110 to the glasses 10.
- the drug carrier 110 is fixed to the eyeglasses 10 and the frame 11 to supply the medicine around the eyes, and the drug carrier 110 has been described in the form of supplying the medicine around the eyes.
- FIG. 8 shows a second embodiment of a spectacle-attached drug carrier device 200.
- the spectacle-type drug carrier device 200 of the present embodiment includes a drug carrier 210 seated on the user's nose and the fixing means for fixing the drug carrier 210 to the glasses 10. .
- the drug carrier 210 has an inverted 'V' shape inclined downward as it extends from the center to both ends, and a drug sheet 220 containing a drug is provided on the bottom surface thereof.
- the spectacle-attached drug carrier device 200 of the present embodiment is to induce the penetration of the medicine that can be fixed on the nose, such as rhinitis or nasal congestion, the herbal components contained in the drug sheet 220 also lotus root, root muscle Extraction and stirring of herbal medicines that help to relieve rhinitis or sinusitis, such as erythema, rhizome root, and sterling.
- the fixing means extends upwardly from the center of the upper surface of the drug carrier 210 and is in the form of a connecting ring 240 that is caught on the connecting frame 13 of the eyeglass 10.
- the nose support seating portion 230 in which the nose support 15 is seated is formed, so that the drug carrier 210 takes the role of the nose support 15 of the glasses 10.
- the drug carrier 110 is mainly expressed in the lens frame 12, but in addition to the drug carrier 110 through the fixing means in the leg frame 14 as illustrated in FIGS. 10 to 12. ) May be attached to allow the drug to be delivered through the skin or mucous membranes.
- a hook member 310 may be installed on the drug carrier 110 to be fixed to the leg frame 14, and may be mounted at the tip of the leg frame 14 through the hook member.
- the front end of the leg frame 14 is adjacent to the lens frame 12, and when the glasses are worn, the front end of the leg frame 14 is not in direct contact with the face but is in a position adjacent to the eye, so that the herbal medicine is easily released into the eye. Can be.
- Velcro tape 320 may be applied as a fixing means for fixing the drug carrier 110 to the leg frame (14).
- the drug carrier 110 is fixed to the leg frame 14 through the velcro tape 320 surrounding the leg frame 14, and the velcro tape 320 can be easily attached and detached so that the drug carrier 110 can be easily replaced. .
- the drug carrier 110 may be fixed to the leg member through various fixing means in addition to the fixing means described above.
- FIG. 13 also shows a form in which the drug carrier 410 can be fastened to the rear end of the leg member 14.
- the drug carrier 410 is formed in the shape of a pocket formed with an insertion groove into which the leg member 14 can be fitted, and the drug carrier 410 is mounted to surround the end of the leg member 14.
- the drug substance of the drug carrier 110 may penetrate into the skin through the skin mucous membrane behind the ear.
- the glasses can be applied to various functional glasses formed for each purpose, such as special glasses for welding, special glasses for experiments, glasses for viewing stereoscopic images, and according to the shape of the drug carrier It is also possible to apply a modified form.
- FIG. 14 illustrates an embodiment in which a plurality of drug carriers 410, 420, 430 are mounted on functional glasses.
- First to third drug carriers 410, 420, 430 are provided on the lens frame 12, the connection frame 13, and the leg frame 14, respectively, and the structure of the drug carrier is the same as that mentioned in the above embodiments. Therefore, description is omitted.
- the glasses are glasses for viewing stereoscopic images, and are equipped with a functional lens 450 capable of performing a corresponding function.
- the correction lens frame 440 equipped with the correction lens 441 for correcting the vision of the wearer may be installed in front of the functional lens 450.
- Corrective lens frame 440 is a magnetic frame and magnetic coupling is made through the magnet in the present embodiment, in addition to the eyeglass through a variety of coupling means, such as a hook method using a ring, the adhesive method through the application of adhesive tape or adhesive material It is installed on the frame to enable viewing of stereoscopic images with corrected vision.
- the corrective lens 441 may be installed to be positioned in front of the functional lens 450, and the coupling means for coupling the corrective lens frame 440 to the spectacle frame may be implemented in various forms. have.
- FIG. 15 illustrates an embodiment in which two first and second guide parts 321 and 322 spaced apart by a predetermined width are formed to attach the drug sheet 310 to the inside of the lens frame 12.
- the first and second guide parts 321 and 322 form an attachment part 323 to which the drug sheet 310 may be attached.
- the attachment portion 323 is provided with a plurality of magnets.
- the base frame 420 is formed to be attached to the inner surface of the lens frame 12 through an adhesive, and the drug sheet 410 is accommodated on the front surface of the base frame 420. And a receiving groove 421 that can be attached, and a cover frame 424 is installed to cover the receiving groove 421.
- a plurality of discharge holes 425 are formed in the cover frame 424 so that the medicine ingredients of the drug sheet 410 can be discharged, and the base formed by the receiving groove 421 on the side of the base frame 420.
- An air hole 422 is formed to allow air to flow into the inner space of the frame 420.
- a shielding plate for covering both sides of the lens to increase the concentration of the screen or book.
- the drug carrier of the present invention has been described as a drug sheet containing a drug substance in the description of the embodiments, the drug carrier is formed of a powder, capsule or gel type containing the drug component in addition to the drug sheet, As in the embodiment, it may be formed in a form filled in the filling space formed by the base frame and the cover frame.
- Glasses-attached drug carrier device of the present invention can be used by attaching to the existing eyeglasses, so the high utilization in daily life, industrial applicability is high.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Vascular Medicine (AREA)
- General Physics & Mathematics (AREA)
- Hematology (AREA)
- Optics & Photonics (AREA)
- Anesthesiology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Eyeglasses (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
Claims (14)
- 약재가 함유된 약물담체와;상기 약물담체를 안경의 프레임에 탈착 가능하게 고정시키기 위한 고정수단;을 구비하는 것을 특징으로 하는 안경 부착형 약물담체 기구장치.
- 제 1항에 있어서,상기 고정수단은 상기 약물담체로부터 연장되며 상기 안경의 프레임에 걸릴 수 있게 단부가 절곡된 고정고리로 된 것을 특징으로 하는 안경 부착형 약물담체 기구장치.
- 제 1항에 있어서,상기 안경의 프레임은 자석과 자력 결합이 가능한 금속재이고,상기 고정수단은 상기 안경프레임에 자력 결합되는 영구자석을 포함하는 것을 특징으로 하는 안경 부착형 약물담체 기구장치.
- 제 1항에 있어서,상기 안경의 프레임에는 상기 약물담체가 부착되는 면에 복수개의 인입홈이 형성되어 있고,상기 고정수단은 상기 약물담체로부터 돌출되며 상기 인입홈에 삽입되는 고정돌기를 포함하는 것을 특징으로 하는 안경 부착형 약물담체 기구장치.
- 제1 항에 있어서,상기 약물담체는 착용자의 콧등에 안착될 수 있게 중앙으로부터 양단으로 연장될수록 하방으로 경사지게 형성되어 있고, 하면에는 상기 약물전달체가 형성되어 있으며,상기 고정수단은 상기 약물담체로부터 상방으로 연장되며 렌즈를 감싸는 렌즈프레임을 상호 연결하는 연결프레임에 걸리는 연결고리로 되며,상기 약물담체의 상면에는 상기 안경의 코받침이 안착되는 코받침 안착부가 마련된 것을 특징으로 하는 안경 부착형 약물담체 기구장치.
- 제 1항에 있어서,상기 고정수단은 상기 약물담체가 상기 안경의 프레임과 접촉하는 접촉면 상에 도포된 접착성 물질로 된 것을 특징으로 하는 안경 부착형 약물담체 기구장치.
- 제 1항 내지 제 6항 중 선택된 어느 한 항에 있어서,상기 약물담체는 상기 고정수단에 의해 상기 안경프레임에 장착되는 베이스프레임과,상기 베이스프레임에 탈부착 가능하게 설치되는 약물시트를 구비하는 것을 특징으로 하는 안경 부착형 약물담체 기구장치.
- 제 7항에 있어서,상기 베이스프레임에는 상기 약물시트의 약재가 용이하게 발산될 수 있도록 상기 약물시트가 부착되는 부착면에 자석부재가 마련된 것을 특징으로 하는 안경 부착형 약물담체 기구장치.
- 제 7항에 있어서,상기 약물담체는 상기 약물시트가 부착된 베이스프레임의 부착면에 결합되며, 상기 약물시트의 약제가 토출될 수 있게 복수개의 토출홀이 형성되어 있는 커버프레임을 더 구비하며,상기 베이스프레임에는 상기 약물시트가 부착된 부착부와 연통되는 통기공이 외부와 상기 부착면을 연통하도록 형성되어 있는 것을 특징으로 하는 안경 부착형 약물담체 기구장치.
- 제 1항 내지 제 6항 중 선택된 어느 한 항에 있어서,상기 안경은 3D 입체영상을 시청하기 위한 편광렌즈가 장착되거나,상기 안경의 프레임에 탈착 가능하게 결합되며 3D 입체영상 시청을 위한 편광렌즈를 포함하는 편광렌즈부를 더 구비하는 것을 특징으로 하는 안경 부착형 약물담체 기구장치.
- 제 1항에 있어서,상기 고정수단은 상기 안경의 프레임에 형성되어 있고, 상기 약물담체가 안착될 수 있는 소정의 안착공간을 제공하는 안착부재를 구비하되,상기 안착부재는 상기 약물시트가 부착되는 부착부와, 상기 부착부의 양측 가장자리에 소정 높이로 돌출된 가이드부를 포함하는 것을 특징으로 하는 안경 부착형 약물담체 기구장치.
- 제 11항에 있어서,상기 안착부재는 상기 부착부에 설치되어 상기 부착부에 부착되는 약물시트에 포함된 약재를 활성화시키는 자석을 더 구비하는 것을 특징으로 하는 안경 부착형 약물담체 기구장치.
- 제 1항에 있어서,상기 안경의 프레임에는 시력교정을 위한 교정용 렌즈를 포함하는 교정렌즈프레임이 착탈 가능하게 결합 설치되는 것을 특징으로 하는 안경 부착형 약물담체 기구장치.
- 제 1항 내지 제 6항 중 선택된 어느 한 항에 있어서,상기 약물담체는 약재성분을 포함하는 분말, 캡슐 또는 겔타입 중 어느 하나의 형태로 형성된 것을 특징으로 하는 안경 부착형 약물담체 기구장치.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013541932A JP2013545144A (ja) | 2010-12-03 | 2011-12-05 | メガネ形態の着用型薬物担体器具装置 |
CN201180064808.0A CN103492017B (zh) | 2010-12-03 | 2011-12-05 | 可附接至眼镜的药物承载器装置 |
US13/990,578 US9398976B2 (en) | 2010-12-03 | 2011-12-05 | Drug carrier device attachable to glasses |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100122737A KR101228602B1 (ko) | 2010-12-03 | 2010-12-03 | 안경 부착형 약물담체 기구장치 |
KR10-2010-0122737 | 2010-12-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012074347A2 true WO2012074347A2 (ko) | 2012-06-07 |
WO2012074347A3 WO2012074347A3 (ko) | 2012-08-23 |
Family
ID=46172440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2011/009365 WO2012074347A2 (ko) | 2010-12-03 | 2011-12-05 | 안경 부착형 약물담체 기구장치 |
Country Status (5)
Country | Link |
---|---|
US (1) | US9398976B2 (ko) |
JP (1) | JP2013545144A (ko) |
KR (1) | KR101228602B1 (ko) |
CN (1) | CN103492017B (ko) |
WO (1) | WO2012074347A2 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102790903A (zh) * | 2012-08-09 | 2012-11-21 | 江苏惠通集团有限责任公司 | 分离式3d眼镜 |
CN103702102A (zh) * | 2013-12-31 | 2014-04-02 | 青岛歌尔声学科技有限公司 | 一种抗干扰的信号处理电路及一种抗干扰3d眼镜 |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150185497A1 (en) * | 2013-11-15 | 2015-07-02 | Patrick C. Ho | Lens Carrier |
JP2017503604A (ja) * | 2014-01-22 | 2017-02-02 | マーシオ マーク アブリュー | Abreu脳熱トンネルでの治療を提供するように構成されたデバイス |
CN104216143A (zh) * | 2014-09-30 | 2014-12-17 | 四川仁心医疗科技有限公司 | 一种可用于眼疾治疗的眼镜架结构 |
US9551882B2 (en) | 2015-03-26 | 2017-01-24 | Alison READ | Headwear with treatment pads |
CN106810717A (zh) * | 2015-11-30 | 2017-06-09 | 鸿富锦精密工业(深圳)有限公司 | 眼用镜片材料及眼用镜片 |
CN106094201A (zh) * | 2016-03-24 | 2016-11-09 | 朱巍 | 一种虚拟现实头盔 |
US20180104516A1 (en) * | 2016-10-13 | 2018-04-19 | Aromeyes, LLC | Nose pad for medicinal application |
CN106726114A (zh) * | 2016-11-30 | 2017-05-31 | 中国人民解放军第九七医院 | 一种用于多种体位眼部烧伤患者的眼部护理装置 |
JP6903315B2 (ja) * | 2017-05-11 | 2021-07-14 | 孔太郎 平井 | 眼鏡フレーム |
US20190290478A1 (en) * | 2018-03-24 | 2019-09-26 | I-Szu Hsia | Medicinal herbal composition for eye application |
EP3908239A4 (en) * | 2019-01-10 | 2022-10-05 | Smartlens, Inc. | METHOD AND DEVICE FOR REMOTE OPTICAL INTRAOCULAR PRESSURE MONITORING |
US20230086646A1 (en) * | 2021-01-14 | 2023-03-23 | Ronald Jerome McCoy | Therapeutic Eyewear Sleeve |
KR102593209B1 (ko) * | 2021-08-09 | 2023-10-25 | 위니스트 주식회사 | 발열포가 포함된 눈 팩 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990001963U (ko) * | 1997-06-24 | 1999-01-15 | 이재용 | 건강보조물을 구비한 안경 |
KR20000015146U (ko) * | 1998-12-31 | 2000-07-25 | 정병은 | 약물투여용 안대 |
KR20030066363A (ko) * | 2002-01-30 | 2003-08-09 | 락 청 | 렌즈가 제거가능하게 장착된 안경 프레임 |
JP2003255280A (ja) * | 2002-02-27 | 2003-09-10 | Horikawa Inc | ダブルフレーム眼鏡 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5935913U (ja) * | 1982-08-27 | 1984-03-06 | 青山眼鏡株式会社 | 眼鏡枠 |
JPS6116532U (ja) * | 1984-06-06 | 1986-01-30 | 博 黒田 | 眼鏡枠 |
US4783163A (en) * | 1986-03-13 | 1988-11-08 | The Spectacle, Inc. | Eyeglass nose pad system |
JPS6340948U (ko) * | 1986-09-03 | 1988-03-17 | ||
JPH0224821U (ko) * | 1988-08-01 | 1990-02-19 | ||
US5307095A (en) * | 1991-01-08 | 1994-04-26 | Rainbow Optical Laboratory Co., Ltd. | Eye-moistening device |
JP2583769Y2 (ja) * | 1991-01-08 | 1998-10-27 | 株式会社レインボーオプチカル研究所 | 眼の加湿構造 |
JP3025888U (ja) * | 1995-11-01 | 1996-06-25 | 哲男 菅野 | 眼 鏡 |
JP3044190U (ja) * | 1997-03-31 | 1997-12-16 | 株式会社村井 | 眼鏡用取り付け具及び眼鏡ホルダー及び眼鏡用装飾具及び前掛けフレーム |
KR19990001963A (ko) | 1997-06-18 | 1999-01-15 | 윤종용 | 전자 렌지용 그릴 석쇠 |
US5907385A (en) * | 1998-08-13 | 1999-05-25 | Flores; Jesse P. | Nose pad and ear pad having two surfaces adhesive |
US7048372B1 (en) * | 2004-11-01 | 2006-05-23 | Haim Cohen | Primary eyeglass lenses magnetically mountable to a frame |
EP1836525A4 (en) * | 2004-12-16 | 2008-12-24 | Yiling Xie | BRACKET WITH REMOVABLE MAGNETIC HELP FRAME |
JP2007020975A (ja) * | 2005-07-20 | 2007-02-01 | Leap:Kk | 療法機能性眼鏡及び眼鏡用療法パッド |
US8292427B2 (en) * | 2005-12-13 | 2012-10-23 | Phyzics Properties Inc. | Screwless magnetic eyewear |
JP4827012B2 (ja) * | 2006-04-13 | 2011-11-30 | 株式会社リーベン | 眼鏡着脱式サングラス |
EA017337B1 (ru) * | 2007-07-19 | 2012-11-30 | Дели Инститьют Оф Фармасьютикал Сайнс Энд Рисерч (Дипсар) | СИНЕРГЕТИЧЕСКАЯ РАСТИТЕЛЬНАЯ КОМПОЗИЦИЯ ПРОТИВ КАТАРАКТЫ, ВКЛЮЧАЮЩАЯ СМЕСЬ ЭКСТРАКТОВ ЛЕКАРСТВЕННЫХ РАСТЕНИЙ Foeniculum vulgare, Murraya koenigii и Triphala |
EP2401870A4 (en) * | 2009-02-27 | 2012-12-26 | Deluxe Lab Inc | SYSTEMS, DEVICES AND METHODS FOR SUBTITLEING STEREOSCOPIC CONTENT |
JP3151465U (ja) * | 2009-03-27 | 2009-06-25 | 百恵 林 | 薬剤供給具 |
CN201477303U (zh) * | 2009-05-27 | 2010-05-19 | 孙梦茹 | 多功能眼镜 |
-
2010
- 2010-12-03 KR KR1020100122737A patent/KR101228602B1/ko active IP Right Grant
-
2011
- 2011-12-05 WO PCT/KR2011/009365 patent/WO2012074347A2/ko active Application Filing
- 2011-12-05 JP JP2013541932A patent/JP2013545144A/ja active Pending
- 2011-12-05 CN CN201180064808.0A patent/CN103492017B/zh active Active
- 2011-12-05 US US13/990,578 patent/US9398976B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990001963U (ko) * | 1997-06-24 | 1999-01-15 | 이재용 | 건강보조물을 구비한 안경 |
KR20000015146U (ko) * | 1998-12-31 | 2000-07-25 | 정병은 | 약물투여용 안대 |
KR20030066363A (ko) * | 2002-01-30 | 2003-08-09 | 락 청 | 렌즈가 제거가능하게 장착된 안경 프레임 |
JP2003255280A (ja) * | 2002-02-27 | 2003-09-10 | Horikawa Inc | ダブルフレーム眼鏡 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102790903A (zh) * | 2012-08-09 | 2012-11-21 | 江苏惠通集团有限责任公司 | 分离式3d眼镜 |
CN103702102A (zh) * | 2013-12-31 | 2014-04-02 | 青岛歌尔声学科技有限公司 | 一种抗干扰的信号处理电路及一种抗干扰3d眼镜 |
Also Published As
Publication number | Publication date |
---|---|
KR20120061421A (ko) | 2012-06-13 |
US20130253451A1 (en) | 2013-09-26 |
WO2012074347A3 (ko) | 2012-08-23 |
CN103492017A (zh) | 2014-01-01 |
JP2013545144A (ja) | 2013-12-19 |
KR101228602B1 (ko) | 2013-01-31 |
US9398976B2 (en) | 2016-07-26 |
CN103492017B (zh) | 2016-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012074347A2 (ko) | 안경 부착형 약물담체 기구장치 | |
JP5694343B2 (ja) | 薬物担体が備えられた顔面部固定支持台 | |
JP2013508070A6 (ja) | 薬物担体が備えられた顔面部固定支持台 | |
CN1964733A (zh) | 肽类化合物治疗特发性震颤及其它震颤综合征的新用途 | |
RU2008138402A (ru) | Полноразмерное устройство для защиты дыхания | |
KR20010071778A (ko) | 불면증의 치료를 위한 gaba 유사체의 용도 | |
DE60218193D1 (de) | Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia | |
CA2362026A1 (en) | Method for the treatment of incontinence | |
US20180104516A1 (en) | Nose pad for medicinal application | |
MD2515G2 (ro) | Metodă de tratament al cataractei | |
US20180045977A1 (en) | Bridgeless glasses | |
CN206339789U (zh) | 一种vr眼镜的支撑构件 | |
CN207734426U (zh) | 一种雾化器面罩 | |
CN206096662U (zh) | 一种助眠健康多功能眼镜 | |
WO2023195562A1 (ko) | 향기캡슐의 선택적인 스마트 제어가 가능한 안경 | |
CN202184903U (zh) | 一种新型镜片可更换式视力保护镜 | |
CN206283492U (zh) | 智能可穿戴头环 | |
CN213430986U (zh) | 一种化工工厂用防毒眼罩 | |
CN213876175U (zh) | 一种稳定佩戴型vr头显设备 | |
WO2018030881A2 (ko) | 맥락막 질환의 치료를 위한 갑상선 호르몬의 용도 | |
CN209253317U (zh) | 一种药物治疗眼罩 | |
CN217245149U (zh) | 一种眼科术后睡眠防压保护眼罩 | |
CN218793355U (zh) | 一种方便病患携带的镇痛泵固定装置 | |
WO2009145662A2 (en) | Method to increase sexual potency and color therapy with a spectacles frame (color therapeutic frame) | |
KR200281384Y1 (ko) | 다용도 안대 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11845445 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase in: |
Ref document number: 2013541932 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13990578 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11845445 Country of ref document: EP Kind code of ref document: A2 |